Grayscale Ethereum Trust (ETH) Common units of fractional undivided beneficial interest (ARCA: ETHE)

에 대한 최신 뉴스 Grayscale Ethereum Trust (ETH) Common units of fractional undivided beneficial interest (ARCA:ETHE)

The Trust holds ETH and, from time to time on a periodic basis, issues Creation Baskets in exchange for deposits of ETH. As a passive investment vehicle, the Trust's investment objective is for the value of the Shares (based on ETH per Share) to reflect the value of ETH held by the Trust, determined by reference to the Index Price, less the Trust's expenses and other liabilities.

Grayscale Ethereum Trust (ETH)

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BTC

$ETH

ETHA

ETHE

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

IBIT

MSTR

최근 증권거래위원회(SEC)에 제출된 13F 공시에 딸면 글로벌 투자은행들이 암호화폐 관련 상장지수펀드(ETF)와 비트코인 대리 종목인 마이크로스트래티지에 대해 상당한 지분을 보유하고 있다는 사실이 밝혀졌다.

JP모건 등 글로벌 투자은행들, 비트코인과 이더리움 ETF에 대거 투자

Grayscale Ethereum Trust (ETH) Common units of fractional undivided beneficial interest

ETHEMA HEALTH CORPORATION by Ethema Health Corporation

Ethema Health Corp

Ethena - United States Dollar

Ethena Staked USDe - United States Dollar

Ethena USDe - United States Dollar

Ether.fi - United States Dollar

Ethereum - TrueUSD

Ethereum - United States Dollar

Ethereum Classic - TrueUSD

Ethereum Classic - United States Dollar

Ethereum Name Service - United States Dollar

Ethereum Push Notification Service

EthereumPoW - United States Dollar

Etherisc DIP Token

Ethernity Chain - United States Dollar

ETHERNITY NETWORKS LTD by Ethernity Networks Ltd.

Ethernity Networks Ltd

Etherpay - United States Dollar

Stephens &amp; Co. analyst Sudan Loganathan initiates coverage on IDEAYA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) with a Overweight rating and announces Price Target of $51.

Price Target

Initiation

Analyst Ratings

IDYA

Stephens & Co. Initiates Coverage On IDEAYA Biosciences with Overweight Rating, Announces Price Target of $51

Macro Economic Events

Global

Economics

China's Xi Calls For More Bridges Of Cooperation, Less 'Small Yard, High Fences'

WIIM

Hyster-Yale shares are trading higher after the company announced approval for a $50 million buyback plan to repurchase 1.5 million shares.

Stephens &amp; Co. analyst Sudan Loganathan initiates coverage on C4 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCCC#NASDAQ">CCCC</a>) with a Equal-Weight rating and announces Price Target of $4.

CCCC

Stephens & Co. Initiates Coverage On C4 Therapeutics with Equal-Weight Rating, Announces Price Target of $4

SMLR

Semler Scientific shares are trading higher after the company announced an increase in BTC and ATM activity and the number of BTC it holds.

Trading Ideas

HCWB

HCW Biologics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 337.9%

Chardan Capital analyst Geulah Livshits maintains Intellia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) with a Buy and raises the price target from $88 to $91.

NTLA

Chardan Capital Maintains Buy on Intellia Therapeutics, Raises Price Target to $91

Evercore ISI Group analyst Peter Levine maintains Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) with a Outperform and raises the price target from $395 to $455.

PANW

Evercore ISI Group Maintains Outperform on Palo Alto Networks, Raises Price Target to $455

China's Xi Says China Will Improve Institutional Mechanism For Opening Up To The Outside World At A High Level; China Will Expand Unilateral Opening Up To The Least Developed Countries

Evercore ISI Group analyst David Palmer maintains Post Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POST#NYSE">POST</a>) with a Outperform and raises the price target from $123 to $126.

POST

Evercore ISI Group Maintains Outperform on Post Hldgs, Raises Price Target to $126

Royal Caribbean Cruises Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) stock has surged to an all-time high of $238.10 in November following Donald Trump's <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41772701/trumps-historic-return-7-ways-his-second-term-could-impact-the-us-economy">presidential election win</a>, as investors anticipate a favorable economic environment for the travel and leisure industry. 
Trump's pro-business policies, including proposed tax cuts for individuals and corporations, could increase disposable income for consumers, potentially driving a surge in discretionary spending on cruises and vacations.
What To Know: Trump's emphasis on deregulation is also seen as a positive for Royal Caribbean. Easing restrictions on the travel industry, particularly those introduced during the pandemic, could streamline operations and reduce compliance costs. This regulatory flexibility may help the cruise operator expand routes and develop new destinations, enhancing its competitive edge.
Read Also: <a href="https://www.benzinga.com/24/11/42035375/how-to-earn-500-a-month-from-walmart-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Walmart Stock Ahead Of Q3 Earnings</a>
Additionally, Trump's stance on energy production could benefit Royal Caribbean by keeping fuel prices stable or even reducing them. With fuel being a significant operating expense for cruise lines, lower energy costs could directly improve Royal Caribbean's profit margins.
The potential rollback of environmental regulations may also have implications for Royal Caribbean's fleet upgrades. While the company has committed to sustainability initiatives, relaxed emissions standards could reduce the urgency and cost of compliance, freeing up resources for growth and marketing.
Furthermore, Trump's broader economic policies, including infrastructure investments, could indirectly benefit Royal Caribbean by enhancing port facilities and boosting international trade and travel. If Trump's administration fosters stronger consumer confidence and economic growth, Royal Caribbean could capitalize on the demand for leisure travel.
Read Also: <a href="https://www.benzinga.com/24/11/42032477/spirit-airlines-eyes-financial-stability-with-chapter-11-filing-and-equity-injection">Spirit Airlines Eyes Restructuring With Chapter 11 Filing And Equity Injection</a>
<h2 class="wp-block-heading">How To Buy RCL Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Royal Caribbean&#8217;s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RCL has a 52-week high of $238.10 and a 52-week low of $102.77.

Why Royal Caribbean Cruises (RCL) Stock Hit A New All-Time High This Month

&nbsp;
Item 1.05 Material Cybersecurity Incident.
&nbsp;
iLearningEngines, Inc. (the "Company") recently became aware of a cybersecurity incident. &nbsp;The ongoing investigation has revealed that a threat actor illegally accessed the Company's environment and certain files on its network, misdirected a $250,000 wire payment, and deleted a number of email messages.&nbsp; The wire payment has not been recovered.
&nbsp;
When it learned of the incident, which has been contained, the Company activated its cybersecurity response plan and launched an internal investigation. The Company engaged a nationally recognized forensic firm and other external advisors to assess and remediate the unauthorized activity. The Company's ongoing investigation and response include continued assessment of impacted systems and data.
&nbsp;
The Company has incurred, and may continue to incur, certain expenses related to its response to this incident. Based on the information available to date, the Company believes that the cybersecurity incident will have a material impact on its operations during the quarter ended December 31, 2024 but does not expect the incident to have a material impact on full year 2024 results. The Company remains subject to various risks due to the incident, including diversion of management's attention, potential litigation, changes in customer or investor behavior, and regulatory scrutiny.

AILE

iLearningEngines Recently Became Aware Of A Cybersecurity Incident; The Ongoing Investigation Has Revealed That A Threat Actor Illegally Accessed The Co's Environment And Certain Files On Its Network, Misdirected A $250,000 Wire Payment, And Deleted A Number Of Email Messages; The Wire Payment Has Not Been Recovered

Evercore ISI Group analyst Vijay Jayant maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Outperform and raises the price target from $128 to $134.

Evercore ISI Group Maintains Outperform on Walt Disney, Raises Price Target to $134

Bonnie-Jeanne Gerety Appointed Interim CFO
Thomas Olivier Appointed Interim COO
Postpones Announcement of 3rd Quarter 2024 Financial Results
BETHESDA, Md., Nov. 18, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) ("iLearningEngines," "ILE" or the "Company") a leader in AI-powered learning and work automation, today announced the appointment of Bonnie-Jeanne Gerety as Interim Chief Financial Officer ("CFO") and the appointment of Thomas Olivier as Interim Chief Operating Officer ("COO"). Farhan Naqvi will continue to serve ILE as Senior Vice President of Corporate Development.

Management

iLearningEngines Announces Bonnie-Jeanne Gerety Appointed Interim CFO; Thomas Olivier Appointed Interim COO; Postpones Announcement Of Q3 2024 Financial Results

Stephens &amp; Co. analyst Sudan Loganathan initiates coverage on Kymera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) with a Overweight rating and announces Price Target of $65.

KYMR

Stephens & Co. Initiates Coverage On Kymera Therapeutics with Overweight Rating, Announces Price Target of $65

D. Boral Capital analyst Jason Kolbert initiates coverage on CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) with a Buy rating and announces Price Target of $34.

CRVO

D. Boral Capital Initiates Coverage On CervoMed with Buy Rating, Announces Price Target of $34

Mary Buffett might not have left her marriage with a lifetime of See's Candies. Still, she did gain something equally valuable: an insider's perspective on <a href="https://www.benzinga.com/news/24/11/41884428/warren-buffetts-166-billion-warning-to-wall-street-has-hit-a-fever-pitch-and-the-financial-world-cant-afford-to-ignore-it">Warren Buffett's investing genius</a>.&nbsp;
<a href="https://www.benzinga.com/personal-finance/24/10/41198368/warren-buffetts-son-who-famously-cashed-in-his-90-000-inheritance-at-19-spends-millions-in-buffe">Married to Warren's son</a>, Peter, from 1980 to 1993, Mary wasn't just an observer; she absorbed the legendary investor's philosophies and made them her own, eventually turning her experience into a successful career as an author, speaker and educator.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li><a href="https://www.benzinga.com/money/cd-valet-growth">CD Popularity Soars: Over 50 Million Americans Embrace Safe Savings with 5–10% Annual Growth</a></li>
</ul>
In a 2019 ThinkAdvisor interview, Mary Buffett offered a glimpse into what it was like to be the daughter-in-law of the billionaire ‘Oracle of Omaha.'
In the early days, Mary had little idea how singular Warren's approach to life – and gift-giving – would be. When she joined the Buffett family, she admits she assumed perks like endless See's Candies would be part of the package. "When I married him, the only thing I knew was that his father owned See's Candies," she recalled. "So when we got married, I was like, great – free candy! Never knowing that there was no free candy with Warren." Instead of sweets, Mary got a front-row seat to the value-investing strategies that have defined Warren's career.
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Though she'd already had a solid foundation in business from her work at Columbia Records to running music publishing at Hugh Hefner's company, Warren's <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">relentless focus on investing</a> soon became a major influence in her life.&nbsp;
Mary says that investing was pretty much all he talked about. She shared in the interview, "That's all he talked about! A couple of times a year we'd go to Omaha and he'd come home and get right on the phone, talking to either Mrs. [Katharine] Graham of the Washington Post or Stan Lipsey [publisher] of The Buffalo News [which Buffett bought in 1977]. He'd be on the phone when you were in the den with him."
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
<a href="https://www.benzinga.com/personal-finance/24/11/41850076/warren-buffett-jokes-hed-be-eating-thanksgiving-dinner-at-mcdonalds-if-it-wasnt-for-uncle-sam-stepping-up">Holidays with the Buffetts</a> were a mini business summit, where conversations with industry titans flowed over dinner instead of eggnog. "When the family got together in Laguna over Christmastime, all the industry titans would be there: We'd have lunches and dinners and they'd all talk about companies. Investing was the only thing Warren ever talked about!" she said.
All that immersion in the investing world paid off for Mary. Inspired by Warren's success and principles, she built her unique career. Today, she's an international speaker and bestselling author of multiple books on Warren Buffett's investment strategies. Her first book, Buffettology, was published in 1997 and became a massive success, leading to a series of books. Her latest, 7 Secrets to Investing Like Warren Buffett, offers readers an accessible entry point into Warren's world of value investing.
See Also: <a href="https://www.benzinga.com/money/100k-cd">$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</a>
Mary's takeaways from her years with the Buffetts come down to timeless principles: patience, discipline and the value of understanding the people behind a business. "The biggest part was watching his discipline and patience and not doing things quickly," she explained. "He'd conduct research and understand the people who were running a company. All of that mattered so much to his success."
While Mary may not have <a href="https://www.benzinga.com/personal-finance/24/06/39551391/warren-buffett-swears-by-his-junk-food-diet-if-id-been-eating-broccoli-and-brussels-sprouts-all-">left the marriage with free chocolate</a>, her time with Warren ultimately gave her something sweeter: the knowledge to build a career helping others understand one of the world's greatest investors.
Read Next:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Warren Buffett's Daughter-in-Law Thought She'd Get 'Free Candy' When She Married His Son – Turns Out, 'There Was No Free Candy With Warren'

Shares of Tesla, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose sharply in today's pre-market trading after a report on Sunday, suggested that the upcoming regulatory framework might ease <a href="https://www.benzinga.com/markets/equities/24/11/42028797/tesla-soars-over-5-in-overnight-trading-as-trump-administration-reportedly-seeks-to-ease-fsd-norms">mandates for self-driving vehicles</a>.
The transition team of President-elect Donald Trump has told advisors that it aims to make a framework for fully self-driving vehicles a priority for the Transportation Department, reported Bloomberg, citing people familiar with the matter.
Tesla shares jumped 8.2% to $347.13 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Apollomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLM#NASDAQ">APLM</a>) gained 80.3% to $0.1725 in pre-market trading after declining 8% on Friday.</li>
<li>Mobile-health Network Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) rose 63% to $0.4238 in pre-market trading after dipping around 12% on Friday.</li>
<li>AtlasClear Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NYSE">ATCH</a>) gained 51.1% to $0.2720 in pre-market trading.</li>
<li>DDC Enterprise Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDC#NYSE">DDC</a>) gained 29.1% to $0.2655 in pre-market trading.</li>
<li>Liberty Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) gained 28% to $21.63 in pre-market trading.</li>
<li>VivoPower International PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVPR#NASDAQ">VVPR</a>) gained 15.1% to $0.9450 in pre-market trading after dipping 39% on Friday.</li>
<li>Intellia Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) climbed 12.7% to $15.75 in pre-market trading after the company said initial Phase 1 data suggesting Nexiguran Ziclumeran, an in vivo CRISPR/Cas9 gene editing therapy, may benefit ATTR Amyloidosis Progression.</li>
<li>Aethlon Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) gained 12.7% to $0.45 in pre-market trading.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) gained 11.1% to $20.64 in pre-market trading after gaining more than 3% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Fly-E Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) shares tumbled 33.2% to $0.4600 in pre-market trading after gaining around 13% on Friday.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) shares fell 28.5% to $1.20 in pre-market trading. CareMax reached agreements to sell Management Services Organization and Core Centers&#8217; assets.</li>
<li>Paramount Gold Nevada Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PZG#NYSE">PZG</a>) shares fell 27.8% to $0.3301 in pre-market trading after gaining around 4% on Friday.</li>
<li>QMMM Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMMM#NASDAQ">QMMM</a>) declined 23.4% to $5.61 in pre-market trading after falling 13% on Friday.</li>
<li>The Arena Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AREN#NYSE">AREN</a>) dipped 23.4% to $1.34 in pre-market trading. Arena Group shares jumped 207% on Friday after it announced its first ever profitable quarter.</li>
<li>Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares dipped 22.1% to $0.9895 in pre-market trading. Siyata Mobile recently reported better-than-expected third-quarter EPS results.</li>
<li>Eterna Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) fell 15% to $0.7100 in pre-market trading after dipping 12% on Friday.</li>
<li>Cyclerion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) fell 14% to $2.22 in pre-market trading after jumping more than 45% on Friday.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) fell 12.3% to $4.43 in pre-market trading after gaining around 9% on Friday. Kingsoft Cloud will release its unaudited financial results for the third quarter before the opening bell on Nov. 19.</li>
<li>Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) fell 9.3% to $0.8890 in today's pre-market trading after declining around 5% on Friday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42024062/how-to-earn-500-a-month-from-apple-stock">How To Earn $500 A Month From Apple Stock</a></li>
</ul>

Pre-Market Outlook

Movers

AEMD

APLM

AREN

ATCH

CMAX

CYCN

ERNA

FLYE

LAZR

LBRT

MNDR

QMMM

SMCI

SYTA

TSLA

VVPR

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

HCW Biologics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCWB#NASDAQ">HCWB</a>) stock is trading higher during Monday premarket with a strong session volume of 10.03 million versus an average volume of 48.02K, as per data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
HCW Biologics and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, have entered into a worldwide exclusive<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42032821/hcw-biologics-and-wy-biotech-announce-license-agreement-for-immunotherapeutic-product-candidate" rel="noreferrer noopener"> license agreement</a>.
The agreement covers the development and commercialization of one of HCW Biologics&#8217; product candidates generated with its new drug discovery platform for therapeutic use.
WY Biotech has agreed to pay HCW Biologics $7.0 million upfront. HCW Biologics is eligible to receive additional significant development milestone payments and double-digit royalties on future product sales.
In addition, HCW Biologics will share a substantial portion of the proceeds from a future transaction(s) involving the molecule if such a transaction occurs.
HCW Biologics also has a payment-free, milestone-free, and royalty-free option to recapture the development and commercialization rights of this molecule for the United States, Canada, Central America, and South America (Opt-in Territory) after the conclusion of the Phase 1 clinical trial.
WY Biotech is financially responsible for all costs associated with the molecule&#8217;s research and development, manufacturing, clinical development, regulatory approval, and commercialization.
If HCW Biologic exercises its opt-in rights, it will be responsible for costs associated with clinical development, regulatory approval, and commercialization in the Opt-in Territory.
As of September 30, 2024, the company said that substantial doubt exists regarding its ability to continue as a going concern for at least 12 months without additional <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41991935/hcw-biologics-reports-third-quarter-2024-financial-results-and-business-highlights" rel="noreferrer noopener">funding or financial support</a>.
The company launched a multi-faceted financing plan in the third quarter of 2024 to raise the capital required through equity financings and business development transactions to fund future product development and operations.
Price Action: HCWB stock is up 237% at $0.99 during the premarket session at last check Monday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42032495/alibaba-eyes-5-billion-bond-sale-to-fund-debt-payoff-and-stock-buybacks" target="_blank" rel="noreferrer noopener">Alibaba Eyes Raising $5 Billion Via Bond Sale to Fund Debt Payoff and Stock Buybacks</a></li>
</ul>

Biotech

Equities

Penny Stocks

Health Care

Contracts

General

Why Is Penny Stock HCW Biologics Surging On Monday?

Stephens &amp; Co. analyst Sudan Loganathan initiates coverage on Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) with a Overweight rating and announces Price Target of $55.

ARVN

Stephens & Co. Initiates Coverage On Arvinas with Overweight Rating, Announces Price Target of $55

Tracking John Paulson's Paulson & Company Portfolio - Q2 2024 Update

Will Fed's easing cycle reverse the tide of ether ETF outflows? Analyst weighs in

The 'Everything Market' Could Last A While Longer

Middle East tensions have shaken the crypto market, as Bitcoin ETFs face massive outflows amid rising unrest. Institutional investors pulled nearly...

Bitcoin ETFs Face Massive Outflows Amid Middle East Tensions

3 Roadblocks To Crypto Adoption

Cryptocurrencies: Bitcoin Climbs Above $60K

ETHE: Ethereum's Quietly Positive October (Rating Downgrade)

Optimal Crypto Allocation For Portfolios

Crypto rally broadens to Cardano, Solana, Shiba Inu and Dogecoin

SA Sentiment: More subscribers open to investing in crypto

AAAU

ACTV

AFMC

AFSM

ARKA

ARKB

ARKC

ARKK

ARKY

AVUV

BAPR

BBRE

BETE

BETH

BGLD

BITB

BITC

BITF

BITO

BITQ

BITS

BITW

BKCH

BLKC

BLOK

BRRR

BSIG

BTCO

BTCW

CETH

CLSK

COIN

CRPT

DAPP

DEFI

ETCG

ETHV

ETHW

EZBC

EZET

FDIG

FIBR

FMCC

FMCCG

FMCCH

FMCCI

FMCCJ

FMCCK

FMCCL

FMCCM

FMCCN

FMCCO

FMCCP

FMCCS

FMCCT

FMCKI

FMCKJ

FMCKK

FMCKL

FMCKM

FMCKN

FMCKO

FMCKP

FNMA

FNMAG

FNMAH

FNMAI

FNMAJ

FNMAK

FNMAL

FNMAM

Comments

Grayscale Ethereum Trust (ETH) Common units of fractional undivided beneficial interest

뉴스

에 대한 최신 뉴스 Grayscale Ethereum Trust (ETH) Common units of fractional undivided beneficial interest (ARCA:ETHE)

월요일, 11월 18, 2024

뉴스

파트너 / 기고자

벤징가 글로벌